[1
]
From the Institute for Stroke and Dementia Research, Klinikum der Universität München,
Ludwig-Maximilians-Universität, Munich, Germany (M.D., R. Malik); Munich Cluster for
Systems Neurology (SyNergy), Munich, Germany (M.D.); Institut für Medizinische Biometrie
und Statistik (I.R.K.), and Institut für integrative und experimentelle Genomik (J.E.),
Universität zu Lübeck, Lübeck, Germany; Universitätsklinikum Schleswig-Holstein, Campus
Lübeck, Germany (I.R.K.); Department of Neurology and Center for Human Genetic Research
(J.R.), and Cardiology Division (C.J.O.D.), Massachusetts General Hospital, Boston;
Harvard Medical School, Boston, MA (J.R.); Program in Medical and Population Genetics
(J.R.), and Program in Medical and Population Genetics (S.K.), Broad Institute of
Harvard and MIT, Cambridge, MA; Clinical Trial Service Unit and Epidemiological Studies
Unit (R.C., J.C.H.), Wellcome Trust Centre for Human Genetics (H.W., M. Farrall),
Department of Cardiovascular Medicine (M. Farrall), and Stroke Prevention Research
Unit, Nuffield Department of Clinical Neuroscience (P.M.R.), John Radcliffe Hospital,
University of Oxford, Oxford, United Kingdom; deCODE Genetics, Reykjavik, Iceland
(S.G., G.T., U.T., K.S.); Department of Medicine, University of Maryland School of
Medicine, Baltimore (B.D.M.); Department of Medicine, Stanford University School of
Medicine, Stanford, CA (T.L.A.); Center for Translational Neuroscience and Mental
Health Research, University of Newcastle, New South Wales, Australia (C.L.); Hunter
Medical Research Institute, New South Wales, Australia (C.L.); National Heart, Lung
and Blood Institute and NHLBI's Framingham Heart Study, MA (C.J.O.D., S.S.); University
of Texas Health Science Center at Houston (M. Fornage); Cardiovascular Health Research
Unit, Department of Epidemiology (B.M.P.), Department of Medicine (B.M.P.), Department
of Health Services (B.M.P.), and Cardiovascular Health Research Unit, Department of
Medicine (J.C.B.), University